Ambalal Sarabhai Enterprises Limited

AMBALALSA6

INE432A01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:17:57 31/05/2024 BST			5-day change	1st Jan Change
47.71 ^INR	-3.40%		+3.83%	+25.49%

05-24	Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
05-24	Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Ambalal Sarabhai Enterprises Ltd. Announces the Demise of O.D. Gulati as Director of the Company

March 01, 2012 at 11:50 am

Ambalal Sarabhai Enterprises Ltd. announced that Dr. O.D. Gulati ceased to be a director of the company with effect from February 23, 2011 due to sad demise.

Latest news about Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-24	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-24	CI
Ambalal Sarabhai Enterprises Limited Approves Appointment of Jinal Shah as Chief Financial Officer, effective July 26, 2024	05-24	CI
Ambalal Sarabhai Enterprises' CFO Resigns	05-02	MT
Ambalal Sarabhai Enterprises Limited Announces Resignation of Navinchandra Patel, Chief Financial Officer with Effect from on or Before July 25, 2024	05-01	CI
Ambalal Sarabhai Enterprises Limited Announces Change in Directorate, Effective 1st April, 2024	03-29	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Ambalal Sarabhai Enterprises Limited Announces Executive Changes	12-30	CI
Ambalal Sarabhai Enterprises Limited Appoints Disha Mahesh Punjani as Company Secretary and Compliance Officer	17/10/23	CI
Ambalal Sarabhai Enterprises Limited Announces Resignation of Damodar H. Sejpal as Company Secretary and Compliance Officer, Effective October 8, 2023	28/09/23	CI
Ambalal Sarabhai Enterprises Limited Appoints Mr. Brijesh Khandelwal as Additional Independent Director	08/09/23	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Ambalal Sarabhai's Arm Begins Operations at New Vadodara, India Unit	12/06/23	MT
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	30/05/23	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/02/23	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09/11/22	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/08/22	CI
Ambalal Sarabha Unit's JV Gets Indian Drug Regulator's Nod to Market Hepatitis C Viral Load Kit	21/04/22	MT
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/02/22	CI
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	13/11/21	CI
Ambalal Sarabhai Enterprises : Unit's Joint Venture Gets Indian Drug Regulator's Nod for Dengue Test Kit	17/09/21	MT
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	11/08/21	CI
Ambalal Sarabhai Enterprises' : Consolidated Profit Climbs in Fiscal Q4	07/06/21	MT
Ambalal Sarabhai Enterprises Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	04/06/21	CI
Ambalal Sarabhai Enterprises : Unit Boost Manufacturing Capacity of Antifungal Antibiotic	12/05/21	MT

Chart Ambalal Sarabhai Enterprises Limited

Duration

Period

Chart Ambalal Sarabhai Enterprises Limited

More charts

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited, is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

Sector

Pharmaceuticals

Calendar

28/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AMBALAL SARABHAI ENTERPRISES LIMITED	+25.49%	43.81M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B

Generic Pharmaceuticals

Ambalal Sarabhai Enterprises Limited

Equities

AMBALALSA6

INE432A01017

Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd. Announces the Demise of O.D. Gulati as Director of the Company

Latest news about Ambalal Sarabhai Enterprises Limited

Chart Ambalal Sarabhai Enterprises Limited

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals